This study enhances our understanding of circRNA functions in HCC development and progression, suggesting that targeting the circPIAS1/miR-455-3p/NUPR1/FTH1 axis could be a promising therapeutic strategy for HCC. Here, FTH1 is linked to hepatocellular carcinoma.